Core Viewpoint - Zhongcheng Zhixin Engineering Consulting Group Co., Ltd. has been approved for IPO by the Beijing Stock Exchange, marking it as the 38th company to pass the review this year, with a focus on providing comprehensive engineering consulting services [1]. Company Overview - Zhongcheng Consulting aims to offer professional technical services including engineering cost, bidding agency, project supervision and management, BIM services, and engineering design [1]. - The company is controlled by Xu Xuele and Lu Jun, with Xu holding a direct stake of 57.40% and an indirect stake of 29.58%, giving them a total voting power of 86.98% [1]. IPO Details - The company plans to publicly issue up to 14 million shares, with an option for an additional 2.1 million shares through an over-allotment option, bringing the total potential issuance to 16.1 million shares [2]. - The funds raised, totaling approximately 199.9 million yuan, will be allocated to projects for building an engineering consulting service network and for research and information technology development [2]. Review Opinions - The review committee has requested the issuer to clarify the authenticity of sales returns from real estate clients and the adequacy of bad debt provisions for accounts receivable [3]. - The committee also inquired about the compliance and innovation of the information system procurement process and the necessity of the information technology construction project [4]. Market Position and Performance - The issuer is required to explain the market potential for its comprehensive consulting and EPC (Engineering, Procurement, and Construction) services, as well as the reasons for performance volatility compared to peers [4].

Core Viewpoint - Zhongcheng Zhixin Engineering Consulting Group Co., Ltd. has received approval for its initial public offering (IPO) on the Beijing Stock Exchange, aiming to raise funds for various projects including engineering consulting service network construction and business expansion [1] Financial Performance - The company reported revenues of 303 million yuan, 368 million yuan, and 396 million yuan for the years 2022, 2023, and 2024 respectively, indicating a revenue growth of 7.39% in 2024 [1] - Net profits for the same years were 64.36 million yuan, 81.06 million yuan, and 105 million yuan, showing a significant increase of 30.02% in 2024 [1] - Key financial metrics for 2024 include: - Revenue: 39.56 million yuan - Net profit attributable to shareholders: 10.54 million yuan - Basic earnings per share: 2.08 yuan - Weighted average return on equity: 33.87% [1]

Group 1 - Four companies are set to present their IPO applications at the upcoming listing committee meetings [1] - Among the companies, Fengbei Biological is expected to raise the most funds, with a target of 750 million yuan for projects including the construction of a 300,000-ton oil acid methyl ester plant and various agricultural microbial products [2][4] - The other companies include Jieke Co., which aims to raise 676 million yuan, Nant Technology with a target of 286 million yuan, and Zhongcheng Consulting planning to raise 200 million yuan [2][6] Group 2 - Fengbei Biological focuses on the comprehensive utilization of waste oil resources and chemical products [4] - Jieke Co. specializes in the research, production, and sales of collaborative robot products, as well as automation system integration [5] - Zhongcheng Consulting provides professional technical services including engineering cost, bidding agency, and project management [6] - Nant Technology is engaged in the research, production, and sales of precision mechanical components [7]